These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35309509)

  • 1. Integrated Analysis of Transcriptomic and Genomic Data Reveals Blood Biomarkers With Diagnostic and Prognostic Potential in Non-small Cell Lung Cancer.
    Kaya IH; Al-Harazi O; Kaya MT; Colak D
    Front Mol Biosci; 2022; 9():774738. PubMed ID: 35309509
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcriptomic data analysis coupled with copy number aberrations reveals a blood-based 17-gene signature for diagnosis and prognosis of patients with colorectal cancer.
    Kaya IH; Al-Harazi O; Colak D
    Front Genet; 2022; 13():1031086. PubMed ID: 36685857
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network Analyses.
    Al-Harazi O; Kaya IH; Al-Eid M; Alfantoukh L; Al Zahrani AS; Al Sebayel M; Kaya N; Colak D
    Front Genet; 2021; 12():710049. PubMed ID: 34659334
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients.
    Der SD; Sykes J; Pintilie M; Zhu CQ; Strumpf D; Liu N; Jurisica I; Shepherd FA; Tsao MS
    J Thorac Oncol; 2014 Jan; 9(1):59-64. PubMed ID: 24305008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Six-Gene Signature Predicts Survival of Adenocarcinoma Type of Non-Small-Cell Lung Cancer Patients: A Comprehensive Study Based on Integrated Analysis and Weighted Gene Coexpression Network.
    Xie H; Xie C
    Biomed Res Int; 2019; 2019():4250613. PubMed ID: 31886214
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrated analysis of the prognostic value of TP53 dependent etoposide-induced gene 24 in non-small cell lung cancer.
    Wang M; Li P; Wan R; Liu X
    Biomed Pharmacother; 2019 Apr; 112():108590. PubMed ID: 30784913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer.
    He R; Zuo S
    Front Oncol; 2019; 9():693. PubMed ID: 31417870
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.
    Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY
    J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values.
    Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H
    Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic biomarkers for major subtypes of non-small-cell lung cancer using genomic and clinical data.
    Lathwal A; Kumar R; Arora C; Raghava GPS
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2743-2752. PubMed ID: 32661603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer.
    Yang CZ; Hu LH; Huang ZY; Deng L; Guo W; Liu S; Xiao X; Yang HX; Lin JT; Sun LL; Lin LZ
    PLoS One; 2021; 16(12):e0260720. PubMed ID: 34855841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.
    Geng JQ; Wang XC; Li LF; Zhao J; Wu S; Yu GP; Zhu KJ
    Tumour Biol; 2016 Feb; 37(2):2257-65. PubMed ID: 26358254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer.
    Wang N; Guo H; Dong Z; Chen Q; Zhang X; Shen W; Bao Y; Wang X
    Cancer Manag Res; 2018; 10():3463-3471. PubMed ID: 30254489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2.
    Galván-Femenía I; Guindo M; Duran X; Calabuig-Fariñas S; Mercader JM; Ramirez JL; Rosell R; Torrents D; Carreras A; Kohno T; Jantus-Lewintre E; Camps C; Perucho M; Sumoy L; Yokota J; de Cid R
    Cancer Treat Res Commun; 2018; 15():21-31. PubMed ID: 30207284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.
    Chen DT; Hsu YL; Fulp WJ; Coppola D; Haura EB; Yeatman TJ; Cress WD
    J Natl Cancer Inst; 2011 Dec; 103(24):1859-70. PubMed ID: 22157961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.